Presentation is loading. Please wait.

Presentation is loading. Please wait.

Fig. 4. Occludin and ZO-1 decrease in cortex of aged SHRs. A

Published byBarbra Curtis Modified over 5 years ago

Similar presentations

Presentation on theme: "Fig. 4. Occludin and ZO-1 decrease in cortex of aged SHRs. A"— Presentation transcript:

1 Fig. 4. Occludin and ZO-1 decrease in cortex of aged SHRs. A
Fig. 4. Occludin and ZO-1 decrease in cortex of aged SHRs.A.Occludin (red) and GFAP (green) immunoreactivity in cortex of age-matched WKY rats (upper row) and aged SHRs (lower row). B. ZO-1 (red) and GFAP (green) immunoreactivity in cortex of age-matched WKY rats (upper row) and aged SHRs (lower row). White asterisks indicate BBB surrounded by astrocyte processes. White arrows refer to decrease of occludin or ZO-1. Bar = 50 μm. Korean J Radiol May-Jun;19(3):

Download ppt "Fig. 4. Occludin and ZO-1 decrease in cortex of aged SHRs. A"

Similar presentations

Figure 1.1 The observer in the truck sees the ball move in a vertical path when thrown upward. (b) The Earth observer views the path of the ball as a parabola.

Figure 1.1 The observer in the truck sees the ball move in a vertical path when thrown upward. (b) The Earth observer views the path of the ball as a parabola.
Fig. 1. 18FDG PET-CT in patient with cutaneous T-cell lymphoma with treatment response. Baseline (A) and post treatment (B) axial fused PET-CT images demonstrate.

Fig FDG PET-CT in patient with cutaneous T-cell lymphoma with treatment response. Baseline (A) and post treatment (B) axial fused PET-CT images demonstrate.
Figure 5. Tbr2 and Tbr2-GFP expression in P7 cortex

Figure 5. Tbr2 and Tbr2-GFP expression in P7 cortex
Fig. 2. The expression of pKr-2 in the substantia nigra (SN) of patients with Parkinson's disease (PD). (A, B) Western blot analysis for pKr-1-2 and pKr-2,

Fig. 2. The expression of pKr-2 in the substantia nigra (SN) of patients with Parkinson's disease (PD). (A, B) Western blot analysis for pKr-1-2 and pKr-2,
Fig. 1 Anti-inflammatory drug treatment reduces the number of reactive microglia in the hippocampus of APPV717I mice. APPV717I transgenic mice (10 months.

Fig. 1 Anti-inflammatory drug treatment reduces the number of reactive microglia in the hippocampus of APPV717I mice. APPV717I transgenic mice (10 months.
Fig. 3. Imaging factors alone in case 14 with cerebellar heterotopia. A. Axial proton density T2-weighted initial MR image (0.3T, non-epilepsy protocol)

Fig. 3. Imaging factors alone in case 14 with cerebellar heterotopia. A. Axial proton density T2-weighted initial MR image (0.3T, non-epilepsy protocol)
Fig. 14. Computed tomography (CT) and schema of transduodenal ampullectomy. A. Schema of transduodenal ampullectomy. Different resection margins between.

Fig. 14. Computed tomography (CT) and schema of transduodenal ampullectomy. A. Schema of transduodenal ampullectomy. Different resection margins between.
Fig year-old man presented with 4-day history of febrile sensation. A

Fig year-old man presented with 4-day history of febrile sensation. A
Fig year-old woman with invasive lobular breast cancer. A

Fig year-old woman with invasive lobular breast cancer. A
Fig. 5. Both imaging and lesion factors in case 3 with focal cortical dysplasia. A. Axial T2-weighted initial MR image (1.5T, non-epilepsy protocol) obtained.

Fig. 5. Both imaging and lesion factors in case 3 with focal cortical dysplasia. A. Axial T2-weighted initial MR image (1.5T, non-epilepsy protocol) obtained.
Seizure - European Journal of Epilepsy

Seizure - European Journal of Epilepsy
Fig. 8. Response to aromatase inhibitor and cyclin dependent kinase inhibitor in metastatic hormone receptor+, HER2 negative breast cancer. In this 29-year-old.

Fig. 8. Response to aromatase inhibitor and cyclin dependent kinase inhibitor in metastatic hormone receptor+, HER2 negative breast cancer. In this 29-year-old.
Fig. 1. Luminal A type breast cancer of 37-year-old woman. A

Fig. 1. Luminal A type breast cancer of 37-year-old woman. A
FIG. 4. (A and B) Microtubule-associated protein-2 (MAP2)/leukemia inhibitory factor (LIF) double-staining immunohistochemistry in the periischemia region.

FIG. 4. (A and B) Microtubule-associated protein-2 (MAP2)/leukemia inhibitory factor (LIF) double-staining immunohistochemistry in the periischemia region.
Aerodrome Lighting Level One 412.02 OHP # 1.

Aerodrome Lighting Level One OHP # 1.
Fig. 5. Wave intensity analysis and concept of instantaneous wave-free ratio (iFR). Upper panel shows example of wave intensity analysis. Different types.

Fig. 5. Wave intensity analysis and concept of instantaneous wave-free ratio (iFR). Upper panel shows example of wave intensity analysis. Different types.
Fig. 4. Proliferation and differentiation of the in vitro repetitive transcranial magnetic stimulation (rTMS) exposed neural stem and progenitor cells.

Fig. 4. Proliferation and differentiation of the in vitro repetitive transcranial magnetic stimulation (rTMS) exposed neural stem and progenitor cells.
Fig. 7. Suspicious lymph nodes (CT features). A

Fig. 7. Suspicious lymph nodes (CT features). A
Fig. 3. Bland-Altman plots of CAC scores between TNC image and MDW (A), MDC (B), MSI (C) images. Mean CAC score from TNC image and VNC images is plotted.

Fig. 3. Bland-Altman plots of CAC scores between TNC image and MDW (A), MDC (B), MSI (C) images. Mean CAC score from TNC image and VNC images is plotted.
From: Blocking Endothelin-B Receptors Rescues Retinal Ganglion Cells from Optic Nerve Injury through Suppression of Neuroinflammation Invest. Ophthalmol.

From: Blocking Endothelin-B Receptors Rescues Retinal Ganglion Cells from Optic Nerve Injury through Suppression of Neuroinflammation Invest. Ophthalmol.

Similar presentations

Ads by Google